Nuno A. Fonseca
机构: Center for Neuroscience and Cell Biology, University of Coimbra, Portugal
每年引用次数
引用次数
引用: 1,406
H-指数: 16
I10-指数 : 17
出版物: 55
Targeting cancer stem cells and non-stem cancer cells: the potential of lipid-based nanoparticles.
Ana Filipa Cruz , Nuno Andre Fonseca , Vera Moura , Sergio Simoes
Current Pharmaceutical Design 23 ( 43) 6563 -6572
7
2017
Nucleolin expression has prognostic value in neuroblastoma patients
Davide Cangelosi , Chiara Brignole , Veronica Bensa , Roberto Tamma
EBioMedicine 85
1
2022
Advances on nucleic acid delivery with nonviral vectors
R.M. Lopes , N.A. Fonseca , A.F. Cruz , A.C. Gregório
Bioinspired Materials for Medical Applications 403 -426
2017
Platform for targeted delivery to stem cells and tumor cells and uses thereof
Nuno Andre Carvalho da Fonseca , Lígia Catarina Gomes Da Silva , Vera Lúcia Dantas Nunes Caldeira De , Ségio Paulo De Magalhães Simões
8
2016
Targeted intracellular delivery of synergistic drug combinations: Tackling drug resistance in human breast cancer
Nuno André Carvalho da Fonseca
Universidade de Coimbra (Portugal)
1
2014
Modelling the impact of nucleolin expression level on the activity of F3 peptide-targeted pH-sensitive pegylated liposomes containing doxorubicin
Bruce Tidor , Adelina Gama , João N Moreira , Vera Moura
Drug Delivery and Translational Research 1 -18
4
2021
Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy.
Chiara Brignole , Maria V Corrias , Laura Emionite , Fabio Pastorino
Journal of Experimental & Clinical Cancer Research 40 ( 1) 180
17
2021
Abstract A101: Nucleolin: A novel cell surface protein for neuroblastoma targeted therapy
Brignole Chiara , Veronica Bensa , Genny Del Zotto , Silvia Bruno
Molecular Cancer Therapeutics 18
2019
The enhanced efficacy of intracellular delivery of doxorubicin/C6-ceramide combination mediated by the F3 peptide/nucleolin system is supported by the downregulation of the PI3K/Akt pathway
Ana F Cruz , Mariana B Caleiras , Nuno A Fonseca , Nelio Goncalves
Cancers 13 ( 12) 3052
5
2021
Nucleolin overexpression predicts patient prognosis while providing a framework for targeted therapeutic intervention in lung cancer
Ângela Valério-Fernandes , Nuno A Fonseca , Nélio Gonçalves , Ana F Cruz
Cancers 14 ( 9) 2217
3
2022
Targeted liposomal doxorubicin/ceramides combinations: The importance to assess the nature of drug interaction beyond bulk tumor cells
Ana Filipa Cruz , Nuno A Fonseca , Ana Rita Malheiro , Joana B Melo
European Journal of Pharmaceutics and Biopharmaceutics 172 61 -77
2
2022
Nucleolin has prognostic value in neuroblastoma patients
Davide Cangelosi , Chiara Brignole , Veronica Bensa , Roberto Tamma
Cancer Research 82 ( 12_Supplement) 1276 -1276
2022
Induction of Human Mesenchymal Stem Cells Osteogenesis by Bioactive Agent-Releasing Liposomes
Nelson Monteiro , Albino Martins , Diana Ribeiro , Susana Faria
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE 6 33 -33
2
2012
Journal Name RSCPublishing
Nelson Monteiro , Albino Martins , Ricardo Pires , Susana Faria
Smpte Journal
In vitro and in vivo tumor models for the evaluation of anticancer nanoparticles
Teresa R Abreu , Mariana Biscaia , Nélio Gonçalves , Nuno A Fonseca
Bio-Nanomedicine for Cancer Therapy 271 -299
9
2021
Differential effect of liposomal C6-ceramide/doxorubicin targeted to nucleolin and conventional combinations against triple negative breast cancer stem cells
Ana F Cruz , Nuno A Fonseca , Nélio Gonçalves , Vera Moura
Cancer Research 79 ( 13 Supplement) 3622 -3622
1
2019
Rational formulation and industrial manufacturing of lipid-based complex injectables: Landmarks and trends
Mariana Biscaia-Caleiras , Nuno A Fonseca , Ana Sofia Lourenço , João Nuno Moreira
Journal of Controlled Release 373 617 -639
6
2024
Moving liposome technology from the bench to the oncological patient: Towards performance-by-design
Ana Filipa Cruz , Nuno A Fonseca , Ana C Gregório , Vera Moura
Particles and Nanoparticles in Pharmaceutical Products: Design, Manufacturing, Behavior and Performance 171 -211
1
2018
In vivo targeting of mesothelioma’s molecular signature with nanoparticle functionalized with nucleolin-binding peptide
Nuno A Fonseca , Vera Moura , Fabiana Colelli , Daniela Pesce
Cancer Research 79 ( 13_Supplement) 2994 -2994
2019
Performance-by-Design
Ana Filipa Cruz , Nuno A Fonseca , Ana C Gregório , Vera Moura
Particles and Nanoparticles in Pharmaceutical Products: Design, Manufacturing, Behavior and Performance 29 171 -171
2018